What ReMedys does – Who we are...

Founders & Management Team

The ReMedys’ team consists of pharmaceutical industry professionals. The team monitors program deliverables, timelines and oversees the general development of projects and the foundation.

Dr. Dawn Toronto

ReMedys Founder and CMC Regulatory Affairs

Dr. Toronto received her PhD from University of California at Davis and has 14 years of international pharmaceutical development experience gained from leadership and technical positions at both contract-manufacturing organizations and in pharmaceutical industry.

Dr. Toronto is the principle of CMCplus, an independent consulting firm, and specializes in developing CMC regulatory strategies from preclinical to phase III clinical trials. She has implemented successful manufacturing and regulatory strategies for over 40 clinical candidates following both EMEA and FDA regulations. She is an expert in the field of analytical method development and validation in accordance with ICH guidelines and maintains a strong background in compliance, quality systems and cGMP production. Dr. Toronto shall focus primarily on developing and sourcing drug supply and ensuring regulatory compliance of materials used in clinical trial studies.

The  Foundation also has networks with professionals in the fields of animal safety/toxicology, regulatory affairs, drug metabolism/ pharmacokinetics, human pharmacology, manufacturing, clinical trial design, statistics, clinical research, clinical trial management, safety, business development, and project management.  Making these experts available as needed to projects ensures state-of-the-art development and increases the likelihood of success.